Digital Enablement of Global Drug Launches: A Case Study of Enterprise IT Readiness for Lenacapavir (HIV-1 Capsid Inhibitor)

Bringing Lenacapavir to global markets revealed serious shortcomings in the manufacturer's computer systems. This innovative HIV-1 capsid inhibitor required a complete digital overhaul centered around SAP S/4HANA implementation. Before this change, product labels varied between countries, supply chains lacked transparency, and regulatory documentation moved through disconnected systems. The SAP integration eliminated these bottlenecks. As a result, patients - especially those with multidrug-resistant HIV infections - received this treatment significantly faster after regulatory approval without compromising safety standards. Unexpectedly, the technology platform built for Lenacapavir became valuable for launching other medications later. Different drug companies struggle with their specific problems, yet this case offers valuable insights about updating old computer systems. Yes, making operations run smoother saves money. But something far more important happens: sick people get life-changing medicines faster. This real-world example proves that smart technology choices help companies deal with complicated regulations without cutting corners on the scientific standards that patients depend on.